Peter Voorhees
34PUBLICATIONS
158CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (34)
Sort by Publication Date:
|Mar 26, 2026
Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study.Binod Dhakal, Moshe Y Levy, Gilbert Ko
|Feb 20, 2026
Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.Shebli Atrash, James Symanowski, Myra Robinson
|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.Aimaz Afrough, Danai Dima, Beatrice Razzo
|Oct 06, 2025
Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses.Laahn Foster, Larry D Anderson, Alfred Chung
|Aug 28, 2025
Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko
Pageof 6
Frequent Collaborators
16 joint publications
Larry D Anderson
12 joint publications
Surbhi Sidana
12 joint publications
Krina Patel
12 joint publications
Douglas W Sborov
11 joint publications
Jack Khouri
10 joint publications
James A Davis
10 joint publications
Shebli Atrash
9 joint publications
Rahul Banerjee
9 joint publications
Doris K Hansen
9 joint publications
Megan M Herr